VetrixBio’s VTX-304 Shows Promise for Canine Osteoarthritis
RALEIGH, North Carolina, June 5, 2026 VetrixBio has announced encouraging first clinical data for VTX-304, its investigational first-in-class bispecific...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
RALEIGH, North Carolina, June 5, 2026 VetrixBio has announced encouraging first clinical data for VTX-304, its investigational first-in-class bispecific...
CLEVELAND, Ohio and HOUSTON, Texas, June 5, 2026 Neuronoff has achieved a major clinical milestone with the successful implantation...
WHITE PLAINS, New York, June 5, 2026 Retia Medical has announced a significant expansion of its commercial partnership with...
Wilmington, Delaware, U.S. | April 15, 2026 AOP Health US, LLC has achieved a significant regulatory milestone with the...
TEL AVIV, ISRAEL — December 8, 2025 — FIZE Medical announced the launch of its FIZE kUO® digital urine-output...
